ArticleInternational journal of hematology2024

High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia.

Shuki Oya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.